503A compounding pharmacies operate under section 503A of the Federal Food, Drug, and Cosmetic Act
TB500 (Thymosin Beta-4 Fragment): A bioactive sequence fragment derived from thymosin beta-4, a ubiquitous actin-binding peptide
Report substrate and SAM concentrations alongside any IC so results can be compared with the published values
This solution is intended strictly for laboratory and research applications, such as diluting or reconstituting compatible research materials under appropriate conditions
Recalls & Warnings February 17, 2026 Rosabella Moringa Capsules Recalled, Linked to Drug-Resistant Salmonella Outbreak On February 13, 2026, Ambrosia Brands, LLC, recalled certain lots of Rosabella Moringa Powder capsules linked with a multi-state outbreak of drug-resistant Salmonella
Number six